Trimodality Approach of Low Dose iOnizing Radiation With or Without Neoadjuvant Pembrolizumab and Prostatectomy for Men With Intermediate/High Risk Prostate Cancer (TALON)

NCT04569461 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Discontinuation of funding

Conditions

Prostate Cancer

Interventions

DRUG: pembrolizumab
RADIATION: Low dose prostate radiation
PROCEDURE: Radical Prostatectomy

Sponsor

Duke University

Collaborators

[object Object]